Kai Tan, PhD, is the lead author of a study conducted on the effectiveness of CelloType. In a press release from CHOP, Tan said, “We are just beginning to unlock the potential of this technology. This approach could redefine how we understand complex tissues at the cellular level, paving the way for transformative breakthroughs in healthcare." Tan, who is also a professor in the Department of Pediatrics at CHOP, continued, “Our findings underscore the increasingly pivotal role technology plays in today's biomedical research. In the same press release, first study author Fuchiang (Rich) Tsui, PhD, endowed chair in Biomedical Informatics and Entrepreneurial Science at Children's Hospital of Philadelphia.

Source: New York Times November 26, 2024 21:05 UTC